Complicaciones médicas e infecciosas del paciente con SARS-CoV-2 Hospitalizados en UCI durante el 2020
| datacite.rights | http://purl.org/coar/access_right/c_16ec | |
| dc.contributor.advisor | Peña Vargas, William Arturo | |
| dc.contributor.advisor | González-Torres, Henry J. | |
| dc.contributor.author | Mulford Palomino, Edwin | |
| dc.contributor.author | Nieves Vélez, Deward Alexis | |
| dc.date.accessioned | 2022-07-18T20:23:58Z | |
| dc.date.available | 2022-07-18T20:23:58Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | Antecedentes: La enfermedad por covid-19 tiene una presentación variable desde casos asintomáticos, hasta casos graves, una proporción de paciente presentan cuadros severos que requieren hospitalización en unidad de cuidados intensivos, esta proporción de paciente por lo general presentan edad avanzadas y consigo comorbilidades asociadas que predisponen a la presentación severa de la enfermedad en muchas ocasiones estos pacientes presentan complicaciones médicas e infecciosas durante su estancia hospitalaria lo que ensombrece el pronóstico y la evolución de los mismos con desenlaces en las mayoría de los casos fatal. Objetivo: Caracterizar las complicaciones médicas e infecciosas del paciente con SARS-CoV-2 Hospitalizados en UCI en una IPS de Magangué (Bol, CO) durante el periodo comprendido entre el 1 de abril y 31 de diciembre del 2020. Materiales y Métodos: Se realizó un estudio de corte retrospectivo, observacional, longitudinal y analítico. Se tomaron todos los pacientes que fueron remitidos a remitidos a la Unidad de Cuidado Intensivo positivos por RT-PCR. El periodo de estudio estuvo comprendido entre abril de 2020 a diciembre de 2020. Los datos acopiados se organizaron en la matriz de carga y se les realizó estadística descriptiva para caracterizar socio-demográficamente a la población en la Unidad de Cuidados Intensivos. Se halló la frecuencia a las variables y se le calculó la proporción de las complicaciones médicas asociadas al SARS-CoV-2 y complicaciones infecciosas de los pacientes en UCI. | spa |
| dc.description.abstract | Background: The disease by covid-19 has a variable presentation from asymptomatic cases, to severe cases, a proportion of patients present severe conditions that require hospitalization in an intensive care unit, this proportion of patients usually present advanced age and associated comorbidities that predispose Due to the severe presentation of the disease, these patients often present medical and infectious complications during their hospital stay, which overshadows their prognosis and evolution, with fatal outcomes in most cases. Objective: To characterize the medical and infectious complications of the patient with SARS-CoV-2 Hospitalized in the ICU at an IPS in Magangué (Bol, CO) during the period between April 1 and December 31, 2020 Materials and Methods: A retrospective, observational, longitudinal and analytical study was carried out. All patients who were referred to the Intensive Care Unit positive by RT-PCR were taken. The study period was from April 2020 to December 2020. The data collected was organized in the load matrix and descriptive statistics were performed to characterize the population in the Intensive Care Unit socio-demographically. The frequency of the variables was found and the proportion of medical complications associated with SARS-CoV-2 and infectious complications of patients in the ICU was calculated. Results: Data from 38 patients who were referred to the ICU were analyzed. 68% were men (p-value: 0.0253). The overall mean age was 66.6±17.7 (men: 69.9±17.1; women: 59.3±17.5 years), with no difference for age by sex (W: 216.0; p-value: 0.0614). Hypertension was the most frequent comorbidity (65.48%). The medical complications associated with SARS-CoV-2 infection hospitalized in the ICU were dyspnea (89.5%), fever (84%) and non-productive cough (81.6%). It was observed that patients with CKD, DM2, Dyslipidemia and CHF tended to have a higher number of complications. | eng |
| dc.format.mimetype | ||
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/10288 | |
| dc.language.iso | spa | |
| dc.publisher | Ediciones Universidad Simón Bolívar | spa |
| dc.publisher | Facultad de Ciencias de la Salud | spa |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | eng |
| dc.rights.accessrights | info:eu-repo/semantics/restrictedAccess | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject | Covid-19 | spa |
| dc.subject | Complicaciones clínicas | spa |
| dc.subject | Unidad de cuidados intensivos | spa |
| dc.subject | Sistema respiratorio | spa |
| dc.subject | Comorbilidades | spa |
| dc.subject | Clinical complications | eng |
| dc.subject | Intensive care unit | eng |
| dc.subject | Respiratory system | eng |
| dc.subject | Comorbidities | eng |
| dc.title | Complicaciones médicas e infecciosas del paciente con SARS-CoV-2 Hospitalizados en UCI durante el 2020 | spa |
| dc.type.driver | info:eu-repo/semantics/other | |
| dc.type.spa | Otros | |
| dcterms.references | West E, Barron DN, Harrison D, Rafferty AM, Rowan K, Sanderson C. Nurse staffing, medical staffing and mortality in Intensive Care: An observational study. Int J Nurs Stud. 2014 May;51(5):781–94. | eng |
| dcterms.references | Blanch L, Abillama FF, Amin P, Christian M, Joynt GM, Myburgh J, et al. Triage decisions for ICU admission: Report from the Task Force of the World Federation of Societies of Intensive and Critical Care Medicine. J Crit Care. 2016 Dec;36(2016):301–5. | eng |
| dcterms.references | Shepherd SJ. Criteria for intensive care unit admission and the assessment of illness severity. Surg. 2018 Apr;36(4):171–9. | eng |
| dcterms.references | Raúl C, Martínez C. La realidad de la Unidad de Cuidados Intensivos. Artículo opinión Med Crit. 2017;31(3):171–3. | spa |
| dcterms.references | Town JA, Churpek MM, Yuen TC, Huber MT, Kress JP, Edelson DP. Relationship Between ICU Bed Availability, ICU Readmission, and Cardiac Arrest in the General Wards. Crit Care Med. 2014 Sep;42(9):2037–41. | eng |
| dcterms.references | Amin P, Fox-Robichaud A, Divatia JV, Pelosi P, Altintas D, Eryüksel E, et al. The Intensive care unit specialist: Report from the Task Force of World Federation of Societies of Intensive and Critical Care Medicine. J Crit Care. 2016 Oct;35(2016):223–8. | eng |
| dcterms.references | Stretch B, Shepherd SJ. Criteria for intensive care unit admission and severity of illness. Surg. 2021 Jan;39(1):22–8. | eng |
| dcterms.references | Christian MD, Sprung CL, King MA, Dichter JR, Kissoon N, Devereaux A V., et al. Triage. Chest. 2014 Oct;146(4):e61S-e74S. | eng |
| dcterms.references | Bulgarelli L, Deliberato RO, Johnson AEW. Prediction on critically ill patients: The role of “big data.” J Crit Care. 2020 Dec;60(2020):64–8. | eng |
| dcterms.references | Sánchez-Casado M, Hostigüela-Martín VA, Raigal-Caño A, Labajo L, Gómez-Tello V, Alonso-Gómez G, et al. Escalas pronósticas en la disfunción multiorgánica: estudio de cohortes. Med Intensiva. 2016 Apr;40(3):145–53. | spa |
| dcterms.references | Balkan B, Essay P, Subbian V. Evaluating ICU Clinical Severity Scoring Systems and Machine Learning Applications: APACHE IV/IVa Case Study. In: 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE; 2018. p. 4073–6. | eng |
| dcterms.references | Wu S-C, Chou S-E, Liu H-T, Hsieh T-M, Su W-T, Chien P-C, et al. Performance of Prognostic Scoring Systems in Trauma Patients in the Intensive Care Unit of a Trauma Center. Int J Environ Res Public Health. 2020 Oct;17(19):7226. | eng |
| dcterms.references | Kelley AMA. Predictive scoring systems in the intensive care unit. 2021;1–32. | eng |
| dcterms.references | Godinjak AG. Predictive value of SAPS II and APACHE II scoring systems for patient outcome in medical intensive care unit. Acta Med Acad. 2016 Dec;45(2):89–95. | eng |
| dcterms.references | Hansted AK, Møller MH, Møller AM, Vester‐Andersen M. APACHE II score validation in emergency abdominal surgery. A post hoc analysis of the InCare trial. Acta Anaesthesiol Scand. 2020 Feb;64(2):180–7. | eng |
| dcterms.references | Moreno RP, Nassar Júnior AP. Is APACHE II a useful tool for clinical research? Rev Bras Ter Intensiva. 2017;29(3):264–7. | eng |
| dcterms.references | Salluh JIF, Soares M. ICU severity of illness scores. Curr Opin Crit Care. 2014 Oct;20(5):557–65. | eng |
| dcterms.references | Schoe A, Bakhshi-Raiez F, de Keizer N, van Dissel JT, de Jonge E. Mortality prediction by SOFA score in ICU-patients after cardiac surgery; comparison with traditional prognostic–models. BMC Anesthesiol. 2020 Dec;20(1):65. | eng |
| dcterms.references | Hess EP, Nestler DM. Transforming the Emergency Department Observation Unit. Cardiol Clin. 2012 Nov;30(4):501–21. | eng |
| dcterms.references | Complicaciones LAS, El EN, Actual E, Medicina DELA. Las complicaciones en el ejercicio actual de la medicina en colombia. 1993; | spa |
| dcterms.references | Taramasso L, Magnasco L, Portunato F, Briano F, Vena A, Giacobbe DR, et al. European Journal of Internal Medicine Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care Nicol o. 2021;(March). | eng |
| dcterms.references | Vassiliou AG, Jahaj E, Orfanos SE, Dimopoulou I, Kotanidou A. Vitamin D in infectious complications in critically ill patients with or without COVID-19. Metab Open. 2021;11:100106. | eng |
| dcterms.references | Pinto ADS. COVID-19 : infarto de miocardio y otros problemas de enfermedad de las arterias coronarias. 2021;1–31. | spa |
| dcterms.references | Tian H, Liu Y, Li Y, Wu C-H, Chen B, Kraemer MUG, et al. An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China. Science (80- ). 2020 May;368(6491):638–42. | eng |
| dcterms.references | Mcintosh K. COVID-19 : Clinical features. 2021; | eng |
| dcterms.references | Guo Z-D, Wang Z-Y, Zhang S-F, Li X, Li L, Li C, et al. Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020. Emerg Infect Dis. 2020 Jul;26(7):1583–91. | eng |
| dcterms.references | Abduljalil JM, Abduljalil BM. Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view. New Microbes New Infect. 2020 May;35:100672. | eng |
| dcterms.references | Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb;395(10223):497–506. | eng |
| dcterms.references | Mcintosh AK. COVID-19 : Epidemiology , virology , and prevention. 2021;1–59. | eng |
| dcterms.references | Lima MA, Silva MTT, Oliveira R V., Soares CN, Takano CL, Azevedo AE, et al. Smell dysfunction in COVID-19 patients: More than a yes-no question. J Neurol Sci. 2020;418(June 2020):117107. | eng |
| dcterms.references | Rozado J, Ayesta A, Morís C, Avanzas P, Sars-cov- DET. Fisiopatología de la enfermedad cardiovascular en pacientes con COVID-19 . Isquemia , trombosis y disfunción cardiaca. Rev española Cardiol Supl. 2021;20:2–8. | spa |
| dcterms.references | Fix O, Grover S. COVID-19: Issues related to liver disease in adults - UpToDate. UpToDate. 2021;1–26. | eng |
| dcterms.references | Asaduzzaman M, Hossain N, Abul M, Shahid A, Alam A. Immune response in COVID-19 : A review. J Infect Public Health. 2021;13(11):1619–29. | eng |
| dcterms.references | Coplen CP, Uhrlaub JL, Nikolich- J. Immune response to COVID-19 in older adults. 2021;147. | eng |
| dcterms.references | Zhou S, Wang Y, Zhu T, Xia L. CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China. Am J Roentgenol. 2020 Jun;214(6):1287–94. | eng |
| dcterms.references | Yu Q, Diab C, Ozen M. Abstract No . 519 The use of arti fi cial ascites in thermal ablation of hepatic lesions : systematic review and meta- analysis Abstract No . 520 Clinical characteristics , imaging manifestations , and outcomes of patients undergoing percutaneous cholecys. J Vasc Interv Radiol. 2021;32(5):S138–9. | eng |
| dcterms.references | Wang K, Kang S, Tian R, Zhang X, Zhang X, Wang Y. Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 ( COVID-19 ) in the Xiaogan area. Clin Radiol. 2021;75(5):341–7. | eng |
| dcterms.references | Fung M, Kaufman DA. Covid-19. 2021; | spa |
| dcterms.references | Karki R, Kanneganti T. The ‘ cytokine storm ’ : molecular mechanisms and therapeutic prospects. Trends Immunol. 2021;42(8):681–705. | eng |
| dcterms.references | Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19 : An overview of the involvement of the chemokine / chemokine-receptor system. Cytokine Growth Factor Rev. 2021;53(May 2020):25–32. | eng |
| dcterms.references | Rizvi S, Danic M, Silver M, Labond V. Cytosorb fi lter : An adjunct for survival in the COVID-19 patient in cytokine storm ? a case report. Hear Lung. 2021;50(1):44–50. | eng |
| dcterms.references | Hu Z, Li S, Song X. Cytokine storm with rapidly elevated interleukin-6 indicates sudden death in patients with critical COVID-19. Cytokine Growth Factor Rev. 2021;58:30–1. | eng |
| dcterms.references | Shoar S. ICU admission and outcome of patients with COVID-19 : Does ICU stay improve survival ? Hear Lung. 2021;50(3):470. | eng |
| dcterms.references | Kim AAY, Gandhi RT. COVID-19 : Management in hospitalized adults. 2021;1–54. | spa |
| dcterms.references | Gargione R. Brazilian ICUs short of drugs and beds amid COVID-19 surge Doctors are reporting shortages of critical drugs and the need to ration care , pointing to public. Lancet. 2021;397(10283):1431–2. | eng |
| dcterms.references | Anesi AGL. COVID-19 : Manejo del adulto intubado. 2021;1–58. | spa |
| dcterms.references | Lampton LM. Covid-19. In: Terapia actual de Conn’s 2021. 2021. p. 554–8. | spa |
| dcterms.references | Mitchell A, Elkind S V, Cucchiara BL, Koralnik IJ. COVID-19 : Neurologic complications and management of neurologic conditions. 2021;12–4. | eng |
| dcterms.references | Alida A, Caforio LP. COVID-19 : Cardiac manifestations in adults. 2021;1–27. | eng |
| dcterms.references | Cohen BA, Wessling EG, Serina PT, Cruz DS, Kim HS, McCarthy DM, et al. Emergency department operations in a large health system during COVID-19. Am J Emerg Med. 2021 Mar;41:241–3. | eng |
| dcterms.references | Polidori MC, Sies H, Ferrucci L, Benzing T. COVID-19 mortality as a fingerprint of biological age. Ageing Res Rev. 2021 May;67(May 2020):101308. | eng |
| dcterms.references | Saragih ID, Advani S, Ph D, Saragih IS, Suarilah I, Susanto I, et al. Frailty as a mortality predictor in older adults with COVID-19 : A systematic review and meta-analysis of cohort studies. Geriatr Nurs (Minneap). 2021;42(5):983–92. | eng |
| dcterms.references | Page GE. African-American COVID-19 Mortality. 2021;75(21):2020–2. | spa |
| oaire.version | info:eu-repo/semantics/acceptedVersion | |
| sb.programa | Especialización en Medicina Crítica y Cuidados Intensivos | spa |
| sb.sede | Sede Barranquilla | spa |